Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.

Suetonia C PalmerBritta TendalReem A MustafaPer Olav VandvikSheyu LiQiukui HaoDavid TunnicliffeMarinella RuospoPatrizia NataleValeria SaglimbeneAntonio NicolucciDavid W JohnsonMarcello TonelliMaria Chiara RossiSunil V BadveYeoungjee ChoAnnie-Claire Nadeau-FredetteMichael BurkeLabib I FaruqueAnita LloydNasreen AhmadYuanchen LiuSophanny TivTanya MillardLucia GagliardiNithin KolanuRahul D BarmanrayRita McMorrowAna Karina Raygoza CortezHeath WhiteXiangyang ChenXu ZhouJiali LiuAndrea Flores RodríguezAlejandro Díaz González-ColmeneroYang WangLing LiSurya SutantoRicardo Cesar SolisFernando Díaz González-ColmeneroRené Rodriguez-GutierrezMichael WalshGordon GuyattGiovanni F M Strippoli

Published in: BMJ (Clinical research ed.) (2021)

PROSPERO CRD42019153180.

Keyphrases

type diabetes
glycemic control
protein protein
cardiovascular disease
amino acid
insulin resistance
binding protein
small molecule